Mavrilimumab may be a potential treatment for giant cell arteritis
Translational study findings have corroborated the role of granulocyte-macrophage colony-stimulating factor (GM-CSF) in upregulating TH1/TH17 pathways and pathogenesis in temporal arteries of patients with giant …